Reports
Sale
Global Pathogen Reduction Systems Market Size, Share, Growth: By Type: Platelet Pathogen Reduction, Plasma Pathogen Reduction; By Applications: Viruses, Fungi, Bacteria, Others; By Product Type: Automated, Semi - Automated; By End User: Hospitals, ASCs, Blood Banks, Others; Regional Analysis; Supplier Landscape; 2024-2032
Global Pathogen Reduction Systems Market Outlook
The global pathogen reduction systems market size is anticipated to grow at a CAGR of 19.8% during the forecast period of 2024-2032, driven by the rising occurrence of emerging infectious diseases that are caused by pathogens, increased focus on transfusion safety to prevent blood borne diseases, and technological advances in this market.
Pathogen Reduction Systems: Introduction
Pathogens are the microorganisms which can potentially cause severe infections and diseases in the human body. Pathogen reduction system refers to the processes and technologies that are used to decontaminate blood and blood products, thereby stopping the spread of infections from the unfiltered blood to the other individual upon transfusion. If a patient requires blood transfusion, it is a necessity that the blood and other blood products like plasma, red blood cells, platelets are free of pathogens, so that when the blood is transfused into previously immunity compromised patient, it does not trigger an immune response against the contaminated blood and blood products.
There are various methods of pathogen reduction which include ultraviolet (UV) light, filtration treatments, and photochemical treatments. UV light and photo chemical treatments damages the nucleic acid of the bacteria’s making them inactive. Blood and blood products can be passed through the bacterial filters with a pore size that would not allow the pathogens to pass through it.
Global Pathogen Reduction Systems Market Segmentation
Based on segments, the market is divided into type, applications, product type, end users, and region.
Market Breakup by Type
- Platelet Pathogen Reduction
- Plasma Pathogen Reduction
Market Breakup by Applications
- Viruses
- Fungi
- Bacteria
- Others
Pathogen Reduction Systems Market Segmentation by Product Type
- Automated
- Semi - Automated
Market Breakup by End Users
- Hospitals
- ASCs
- Blood Banks
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Pathogen Reduction Systems Market Overview
The growth of the market is driven by the increasing prevalence of infectious diseases caused by the transfusion of contaminated blood and blood products, rising awareness about the infections caused by the transfusion, blood safety regulations and technological advances.
Regulatory bodies have stringent guidelines and standards for blood safety for the well-being of the population. These regulations compel the healthcare facilities, blood banks, and transfusion centres to incorporate the pathogen reduction systems, adding to the overall pathogen reduction systems market value. Premises that are approved by regulatory bodies for their practices helps in the development of trust amongst general public. Technological advances in this field have led to the development of systems that destroy the pathogens in the blood products without compromising the properties of blood and its components.
The COVID-19 pandemic has increased the awareness about the pathogen transmitted infections and the importance of blood safety and infection curbing measures, which has tremendously fuelled the demand of pathogen reduction systems in the past few years.
The pathogen reduction systems market demand has been witnessing significant growth over the past few years and it is likely to register growth in the coming years as well. This can be attributed to the rising prevalence of infectious diseases, along with the rising investment in innovative and technologically developed products.
Based on regional outlook, North America is anticipated to account for the largest pathogen reduction systems market share owing to the developed and advanced healthcare sector in the region. Additionally, the growing demand for the product can also be attributed to the rising adoption of advanced products and the rising investment by the government.
With the rising launches of technological advanced products, the demand for these systems is rising across the globe. Besides North America, rapidly developing Asia Pacific region is also set to register remarkable growth over the coming years due to the rising emphasis of the government on the development and expansion of healthcare infrastructure.
Pathogen Reduction Systems Market Competitive Landscape
The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model, along with giving a SWOT analysis. The report gives a detailed analysis of the following pathogen reduction system companies, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
- Terumo BCT, Inc.
- Macopharma SA
- Cerus Corporation
- AngioDynamics, Inc.
- Octapharma AG
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Applications |
|
| Breakup by Product Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Pathogen Reduction Systems Market Overview
3.1 Global Pathogen Reduction Systems Market Historical Value (2017-2023)
3.2 Global Pathogen Reduction Systems Market Forecast Value (2024-2032)
4 Global Pathogen Reduction Systems Market Landscape
4.1 Global Pathogen Reduction Systems Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Pathogen Reduction Systems Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Applications
5 Global Pathogen Reduction Systems Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Pathogen Reduction Systems Market Segmentation
6.1 Global Pathogen Reduction Systems Market by Type
6.1.1 Market Overview
6.1.2 Platelet Pathogen Reduction
6.1.3 Plasma Pathogen Reduction
6.2 Global Pathogen Reduction Systems Market by Applications
6.2.1 Market Overview
6.2.2 Viruses
6.2.3 Fungi
6.2.4 Bacteria
6.2.5 Others
6.3 Global Pathogen Reduction Systems Market by Product Type
6.3.1 Market Overview
6.3.2 Automated
6.3.3 Semi - Automated
6.4 Global Pathogen Reduction Systems Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 ASCs
6.4.4 Blood Banks
6.4.5 Others
6.5 Global Pathogen Reduction Systems Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Pathogen Reduction Systems Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Pathogen Reduction Systems Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Pathogen Reduction Systems Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Pathogen Reduction Systems Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Pathogen Reduction Systems Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Terumo BCT, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Macopharma SA
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Cerus Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 AngioDynamics, Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Octapharma AG
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
18 Global Pathogen Reduction Systems Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market is anticipated to grow at a CAGR of 19.8% during the forecast period of 2024-2032.
The growth of the market is driven by the rising prevalence of infectious diseases that are caused by pathogens, increased focus on transfusion safety to prevent blood borne diseases, and technological advances in this market.
The key trends which are bolstering the market growth include integration with digital health technologies and increasing adoption of real time surveillance.
The product types in the market include platelet and plasma pathogen reduction type.
The product types in the market include automated and semi-automated.
The system finds wide application in viruses, bacteria, and fungi, among others.
The end-users in the market are hospitals, ambulatory surgery centres (ASCs), and blood banks, among others.
The major regional markets include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
The key players in the market can be categorised into Terumo BCT, Inc., Macopharma SA, AngioDynamics, Inc., Octapharma AG., and Cerus Corporation.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER